Search
SNDL Inc
SNDLAdd to Watchlist
1.425USD
-0.015-1.04%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
375.29MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-17The current earnings forecast score of SNDL Inc is 8.00, ranking 55 out of 157 in the Pharmaceuticals industry. The average price target is 5.60, with a high of 6.20 and a low of 5.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.577
Target Price
+150.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
SNDL Inc
SNDL
2
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is SNDL Inc's expected revenue for the next quarter?
SNDL Inc's expected revenue is 168.82M.
What is SNDL Inc's price target?
Analysts forecast that SNDL Inc's price target is USD 5.60, with the highest forecast at USD 6.20 and the lowest forecast at USD 5.00.
How have SNDL IncSNDL's recent earnings per share performed?
The market expectation was USD -0.03, while SNDL IncSNDL's earnings per share (EPS) for the previous quarter was USD 0.03. EPS for the next quarter is expected at USD -0.00.
What is the analyst rating for SNDL Inc?
Based on the ratings of SNDL Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
